Literature DB >> 17346684

Early inhibition of TNFalpha increases 6-hydroxydopamine-induced striatal degeneration.

Carmelina Gemma1, Briony Catlow, Michael Cole, Charles Hudson, Amy Samec, Nishan Shah, Jennifer Vila, Adam Bachstetter, Paula C Bickford.   

Abstract

Evidence suggests that tumor necrosis factor alpha (TNF) is a leading cause of dopaminergic neuronal cell death. TNF also, however, has neuroprotective effects. Thus, TNF might have a dual role following injury: immediate release after injury is protective, whereas chronic increases are detrimental. In the present study, 6-hydroxydopamine was used to lesion the dorsal striatum in male Fisher 344 rats at 2 different time points. Group 1 received a daily injection of TNFalpha antisense oligodeoxyribonucleotide (ODN) or control on days 1 through 7 post-lesion. Group 2 received a daily injection of TNF antisense ODN or control on days 5 through 15 post-lesion. Rats were killed on the day following the last injection of TNF antisense ODN. Injection of TNF antisense ODN on days 1 through 7 increased the area of the tyrosine-hydroxylase-negative zone ipsilateral to the injection when compared to controls. In contrast, when inhibition of TNF was delayed, the area of tyrosine hydroxylase loss was significantly reduced. These findings suggest that TNF release is neuroprotective in the early stages of injury but becomes neurotoxic when chronically induced.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346684     DOI: 10.1016/j.brainres.2007.02.003

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

2.  Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene.

Authors:  Heather A Boger; Lawrence D Middaugh; Vandana Zaman; Barry Hoffer; Ann-Charlotte Granholm
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

3.  Dual effects of TNFalpha on nerve fiber formation from ventral mesencephalic organotypic tissue cultures.

Authors:  Franziska Marschinke; Ingrid Strömberg
Journal:  Brain Res       Date:  2008-04-09       Impact factor: 3.252

4.  Monocytes are essential for the neuroprotective effect of human cord blood cells following middle cerebral artery occlusion in rat.

Authors:  T A Womble; S Green; M Shahaduzzaman; J Grieco; P R Sanberg; K R Pennypacker; A E Willing
Journal:  Mol Cell Neurosci       Date:  2014-01-25       Impact factor: 4.314

Review 5.  Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?

Authors:  Rohit Kumar Tiwari; Afrasim Moin; Syed Mohd Danish Rizvi; Syed Monowar Alam Shahid; Preeti Bajpai
Journal:  Metab Brain Dis       Date:  2021-03-11       Impact factor: 3.584

6.  A spirulina-enhanced diet provides neuroprotection in an α-synuclein model of Parkinson's disease.

Authors:  Mibel M Pabon; Jennifer N Jernberg; Josh Morganti; Jessika Contreras; Charles E Hudson; Ronald L Klein; Paula C Bickford
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease.

Authors:  Mibel M Pabon; Adam D Bachstetter; Charles E Hudson; Carmelina Gemma; Paula C Bickford
Journal:  J Neuroinflammation       Date:  2011-01-25       Impact factor: 8.322

Review 8.  Sirt3, mitochondrial ROS, ageing, and carcinogenesis.

Authors:  Seong-Hoon Park; Ozkan Ozden; Haiyan Jiang; Yong I Cha; J Daniel Pennington; Nukhet Aykin-Burns; Douglas R Spitz; David Gius; Hyun-Seok Kim
Journal:  Int J Mol Sci       Date:  2011-09-23       Impact factor: 5.923

9.  Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?

Authors:  María C Leal; Juan C Casabona; Mariana Puntel; Fernando J Pitossi
Journal:  Front Cell Neurosci       Date:  2013-04-29       Impact factor: 5.505

Review 10.  A New Venue of TNF Targeting.

Authors:  Sophie Steeland; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Int J Mol Sci       Date:  2018-05-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.